Biological Assembly 1  

 3D View: Structure | Electron Density | Ligand Interaction

Standalone Viewers  
Protein Workshop | Ligand Explorer

Global Symmetry: Asymmetric - C1 
Global Stoichiometry: Monomer - A 

Biological assembly 1 assigned by authors and generated by PISA (software)

Macromolecule Content

• Total Structure Weight: 34834.27 
• Atom Count: 2268 
• Residue Count: 302 
• Unique protein chains: 1

3LQ8

Structure of the kinase domain of c-Met bound to XL880 (GSK1363089)

• DOI: 10.2210/pdb3LQ8/pdb

• Classification: TRANSFERASE
• Organism(s): Homo sapiens
• Expression System: Spodoptera frugiperda


• Deposited: 2010-02-08 Released: 2010-05-19 
• Deposition Author(s): Lougheed, J.C., Stout, T.J.

---

Experimental Data Snapshot

• Method: X-RAY DIFFRACTION
• Resolution: 2.02 Å
• R-Value Free: 0.252 
• R-Value Work: 0.191 

Literature

Inhibition of tumor cell growth, invasion, and metastasis by EXEL-2880 (XL880, GSK1363089), a novel inhibitor of HGF and VEGF receptor tyrosine kinases.

Qian, F., Engst, S., Yamaguchi, K., Yu, P., Won, K.A., Mock, L., Lou, T., Tan, J., Li, C., Tam, D., Lougheed, J., Yakes, F.M., Bentzien, F., Xu, W., Zaks, T., Wooster, R., Greshock, J., Joly, A.H.

(2009) Cancer Res. 69: 8009-8016

• PubMed: 19808973 
• DOI: 10.1158/0008-5472.CAN-08-4889


• PubMed Abstract: 
  

The Met receptor tyrosine kinase and its ligand, hepatocyte growth factor (HGF), are overexpressed and/or activated in a wide variety of human malignancies. Vascular endothelial growth factor (VEGF) receptors are expressed on the surface of vascular endothelial cells and cooperate with Met to induce tumor invasion and vascularization. EXEL-2880 (XL880, GSK1363089) is a small-molecule kinase inhibitor that targets members of the HGF and VEGF receptor tyrosine kinase families, with additional inhibitory activity toward KIT, Flt-3, platelet-derived growth factor receptor beta, and Tie-2. Binding of EXEL-2880 to Met and VEGF receptor 2 (KDR) is characterized by a very slow off-rate, consistent with X-ray crystallographic data showing that the inhibitor is deeply bound in the Met kinase active site cleft. EXEL-2880 inhibits cellular HGF-induced Met phosphorylation and VEGF-induced extracellular signal-regulated kinase phosphorylation and prevents both HGF-induced responses of tumor cells and HGF/VEGF-induced responses of endothelial cells. In addition, EXEL-2880 prevents anchorage-independent proliferation of tumor cells under both normoxic and hypoxic conditions. In vivo, these effects produce significant dose-dependent inhibition of tumor burden in an experimental model of lung metastasis. Collectively, these data indicate that EXEL-2880 may prevent tumor growth through a direct effect on tumor cell proliferation and by inhibition of invasion and angiogenesis mediated by HGF and VEGF receptors.

---

Organizational Affiliation: 

Exelixis, Inc, South San Francisco, California 94083, USA.

Macromolecules

Find similar proteins by: Sequence  |  Structure

Entity ID: 1
Molecule	Chains	Sequence Length	Organism	Details
Hepatocyte growth factor receptor	A	302	Homo sapiens	Mutation(s): 0  Gene Names: MET EC: 2.7.10.1
Find proteins for P08581 (Homo sapiens) Go to Gene View: MET Go to UniProtKB:  P08581

Small Molecules

Ligands 1 Unique
ID	Chains	Name / Formula / InChI Key	2D Diagram & Interactions
88Z	A	N-(3-fluoro-4-{[6-methoxy-7-(3-morpholin-4-ylpropoxy)quinolin-4-yl]oxy}phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide C34 H34 F2 N4 O6 CXQHYVUVSFXTMY-UHFFFAOYSA-N

External Ligand Annotations
ID	Binding Affinity (Sequence Identity %)
88Z	IC50: 0.4 - 14 nM (99) BINDINGDB
88Z	IC50: 0.4 nM BINDINGMOAD
88Z	IC50: 0.4 nM PDBBIND

Experimental Data & Validation

Experimental Data

• Method: X-RAY DIFFRACTION
• Resolution: 2.02 Å
• R-Value Free: 0.252 
• R-Value Work: 0.191 
• Space Group: P 1 2₁ 1

Unit Cell:

Length (Å)	Angle (°)
a = 37.925	α = 90.00
b = 43.017	β = 91.61
c = 89.618	γ = 90.00

Software Package:

Software Name	Purpose
MOSFLM	data reduction
SCALA	data scaling
MOLREP	phasing
REFMAC	refinement
CrystalClear	data collection

Structure Validation

Entry History 

Deposition Data

• Deposited Date: 2010-02-08 
• Released Date: 2010-05-19 
• Deposition Author(s): Lougheed, J.C., Stout, T.J.

Revision History 

• Version 1.0: 2010-05-19
  Type: Initial release
• Version 1.1: 2011-07-13
  Type: Version format compliance